June 25-26, 2020

3rd Annual MarketsandMarkets Next-Gen Immuno-Oncology Congress - Virtual Event (Time Zone - EST)

45+

Speakers

200+

Attendees

Networking Hours

Sessions

Due to growing concerns about COVID-19, the 3rd Annual MarketsandMarkets Next Gen IO Congress is going fully virtual this year. We are disappointed that we are not able to come together in person in June for this event, but we are so thrilled to see you on an online platform. We are working together to create a virtual conference that will be beneficial and engaging for speakers, attendees and sponsors/exhibitors.

See the Post Show report of our 2nd Annual here

Please write to event@marketsandmarket.com for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.

WHAT TO EXPECT

Key Highlights

Immune Checkpoint Inhibitors and Combinations
Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
Monoclonal Antibody & Cellular Therapy
Neoantigens in personalized Cancer Immunotherapy
Biomarkers and Cancer Vaccines
Developments in CAR-T Cellular Therapy
Oncolytic Viral Therapy & Personalized Medicine
Engineering Cellular Therapies Beyond Traditional Tumor Antigens
Combination Therapies in I/O

Why attend Virtual?

Exclusive Virtual event to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
Find out new case studies of immune-oncology projects in development
Contribute to interactive Q&A sessions with your peers to deliberate key topics most relevant to you
Explore the latest platforms and technologies on the market for development
Discuss the best tool for your research in immune-oncology